Electrostatic Sprayers: A New Way to Combat C. difficile in Healthcare

Clostridioides difficile (C. difficile) costs U.S. acute care facilities $1.5 billion and causes almost 500,000 illnesses annually. Given this is a growing and impactful threat within the healthcare community,  Clorox Healthcare developed Spore Defense Cleaner Disinfectant for electrostatic sprayers to help healthcare facilities more effectively and efficiently combat the spread of C. diff. Electrostatic technology works by charging and atomizing the disinfection solution allowing it to reach and uniformly coat surfaces, even those easily missed by manual cleaning, for superior surface coverage, easing application and effectiveness of disinfection protocols for healthcare facilities. The following presentation, developed and presented by Katherine Velez, Ph.D, Senior Scientist, Clorox Professional Products Company, details the growing threat of C. diff, its impact on patients and healthcare facilities, how it spreads, the importance and role of disinfection in preventing its spread, and the benefits of implementing electrostatic technology, including the use of Spore Defense, in healthcare facilities.